| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 5q14 |
GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C, USH2B |
G protein-coupled receptor 98 |
602851 |
Convulsions, familial febrile, 4, 604352 (3); Usher syndrome, typeIIC, 605472 (3) |
|
A, REc, R, Fd |
13(Frings, mass1) |
| 4q21 |
ANXA3, ANX3 |
Annexin A3 (lipocortin III) |
106490 |
|
|
Psh, REa, A |
|
| 4q21 |
ARHGAP24, RCGAP72, FILGAP |
RHO GTPase-activating protein 24 |
610586 |
|
|
REc |
|
| 4q21 |
CDS1 |
CDP-diacylglycerol synthase 1 |
603548 |
|
|
R, A |
|
| 4q21 |
CXCL9, MIG, SCYB9 |
Chemokine, C-X-C motif, ligand 9 |
601704 |
|
close to INP10 |
A, REn |
|
| 4q21 |
CXCL10, INP10 |
Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10) |
147310 |
|
?involved in monocytic leukemia with t(4;11)(q21;q23) |
A, REa, F |
|
| 4q21 |
CXCL13, SCYB13, BCA1, BLC |
Chemokine, C-X-C motif, ligand 13 |
605149 |
|
|
REc |
|
| 4q21 |
DMP1, ARHR, ARHP |
Dentin matrix acidic phosphoprotein |
600980 |
Hypophosphatemic rickets, AR, 241520 (3) |
|
Fd, REn, Psh, A |
|
| 4q21 |
ENAM, AIH2, AI1C |
Enamelin |
606585 |
Amelogenesis imperfecta, type IB, 104500 (3);Amelogenesis imperfecta, type IC, 204650 (3) |
|
REc |
|
| 4q21 |
FGF5 |
Fibroblast growth factor-5 |
165190 |
|
|
REa, A |
5(Fgf5) |
| 4q21 |
FRAS1 |
FRAS1 gene |
607830 |
Fraser syndrome, 219000 (3) |
|
Fd |
5(bl, Fras1) |
| 4q21 |
HEL308 |
DNA helicase Hel308 |
606769 |
|
|
H |
5(Hel308) |
| 4q21 |
HIES |
Hyper-IgE syndrome |
147060 |
Hyper-IgE syndrome (2) |
|
Ch, Fd |
|
| 4q21 |
HSD17B11, RETSDR2, PAN1B |
17-beta-hydroxysteroid dehydrogenase XI |
612831 |
|
|
R, REc |
|
| 4q21 |
IGJ |
Immunoglobulin J polypeptide, linker protein for |
147790 |
|
|
REa, A |
5(Igj) |
| 4q21 |
LGMD1G |
Limb-girdle muscular dystrophy, type 1G |
609115 |
Limb-girdle muscular dystrophy, type 1G (2) |
max lod at D4S2964 |
Fd |
|
| 4q21 |
SLC4A4, NBC1, KNBC, SLC4A5 |
Solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
603345 |
Renal tubular acidosis, proximal, with ocular abnormalities,604278 (3) |
|
Psh |
|
| 4q21 |
SNCA, NACP, PARK1, PARK4 |
Synuclein, alpha (non A4 component of amyloid precursor) |
163890 |
Parkinson disease, familial, 168601 (3); Parkinson disease 4,autosomal dominant Lewy body, 605543 (3); Dementia, Lewy body, 127750 (3) |
|
Psh, A, Fd |
|
| 4q21 |
UTP3, CRL1, CRLZ1 |
UTP3, S. crevisiae, homolog of |
611614 |
|
|
REc |
5(Utp3) |
| 4q21-q22 |
COQ2 |
CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial) |
609825 |
Coenzyme Q10 deficiency, 607426 (3) |
|
REc |
|
| 4q21-q22 |
HPGDS, PGDS |
Prostaglandin D2 synthase, hematopoietic |
602598 |
|
|
A |
3(Pgds) |